Nestle's Vitamins Business Sale Should Lead to Minimal Earnings Dilution

Dow Jones
昨天

0619 GMT - Nestle's $1 billion deal to sell its mainstream vitamins, minerals and supplements business to private-equity group Yellow Wood Partners should result in a minimal dilution of the Swiss food giant's earnings, J.P. Morgan analysts say in a research note. The business generated roughly 1.1% of Nestle's sales last year and was a lower-margin part of the group's portfolio, according to JPM. Nestle will keep premium vitamins, minerals and supplements brands like Solgar and Pure Encapsulations. "The combination of the mainstream and premium [vitamins, minerals and supplements] businesses brought scale and breadth of brands that had manufacturing and [route-to-market] synergies that have since become less relevant, and Nestle has emphasized the strong performance of the premium [vitamins, minerals and supplements] business," the analysts say.

 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10